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Aims: There is inconsistent evidence on whether prior spinal fusion surgery adversely impacts outcomes 
following total hip arthroplasty (THA). We conducted a systematic review and meta-analysis to assess the 
association between pre-existing spinal fusion surgery and the rate of complications following primary THA. 
 
Materials and Methods: We searched MEDLINE, Embase, Web of Science, and Cochrane Library up to 
October 2019 for randomised controlled trials (RCTs) and observational studies comparing outcomes of 
dislocation, revision, or reasons for revision in patients following primary THA with or without pre-existing 
spinal fusion surgery. Furthermore, we compared short (2 or less levels) or long (3 or more levels) spinal 
fusions to no fusion. Summary measures of association were relative risks (RRs) (with 95% confidence 
intervals, CIs).  
 
Results: We identified 10 articles corresponding to 9 unique observational studies comprising of 1,992,366 
primary THAs. No RCTs were identified. There were 32,945 cases of spinal fusion and 1,752,362 non-cases. 
Comparing prior spinal fusion versus no spinal fusion in primary THA, RRs (95% CIs) for dislocation 2.23 
(1.81-2.74) (7 studies), revision 2.14 (1.63-2.83) (5 studies), periprosthetic joint infection 1.71 (1.53-1.92) (4 
studies), periprosthetic fracture 1.52 (1.28-1.81) (3 studies), aseptic loosening 1.76 (1.54-2.01) (3 studies), and 
any complications 2.82 (1.37-5.80) (3 studies) were identified. Both short or long spinal fusion when 
compared with no fusion were associated dislocation, revision, or reasons for revision.  
 
Conclusions: Patients with prior spinal fusion are at risk of adverse events following primary THA. Measures 
that reduce the risk of these complications should be considered in this high-risk population when undergoing 
primary THA. These patients should also be counselled appropriately around their risks of undergoing THA.  
 
Bullet points:  
Patients with prior spinal fusion are at an increased risk of adverse events, including dislocation, aseptic 











As patient populations age there is an increasing burden of disability from osteoarthritis of the hip 
and degenerative disease of the spine fuelling an ever increasing requirement for total hip 
arthroplasty (THA) and spinal fusion.1,2 Independently, these two procedures carry challenges which are 
compounded when both hip and spine degeneration coexist. Statically, the alignment of the lumbar spine 
affects pelvic and therefore hip position. Commonly, this is recognised with a lumbar scoliosis causing pelvic 
obliquity, but similarly, sagittal spinal malalignment is partially compensated for by pelvic version.3 
Dynamically, stiffness of the lumbar spine requires compensation by the hips to achieve spinopelvic range of 
motion.4 Thus, lumbar fusion, which affects the spine’s alignment and range of motion, induces static and 
dynamic effects on the pelvis. Therefore, in patients with a lumbar fusion contemplating THA, the 
implications of their reduced spinal movement and position of the spine fusion needs to be understood.5 
 
Of particular importance in THA, is optimising the cup’s position to reduce edge loading, squeaking, 
impingement and dislocation. While historically, Lewinnek  and Grammatopoulos 6,7 safe zones were 
proposed as predictive measures for hip dislocation and edge loading respectively, these measurements rely 
on a single standing antero-posterior (AP) pelvic radiograph and therefore fail to assess the individual’s static 
sagittal alignment or dynamic spinopelvic motion. This may, at least in part, explain why they have shown to 
not adequately predict the risk of dislocation and wear. 8,9 More recently, a recognition of spinopelvic 
kinematics has emphasised the importance of the functional acetabular orientation 10 and the importance of 
spinal mobility on THA outcomes.11,12 Yet, despite recognising these effects, the implications of previous 
spinal fusions and quantification of the effect on the outcomes of THA remain controversial.  
 
Previous reports and systematic reviews of the published literature have attempted to evaluate the effects of 
lumbar fusion on THA. Riviere and colleagues performed a systematic review of various spinopelvic 
radiological parameters and found a significant relationship between these parameters on THA impingement 
and dislocation.13 In 2017, An and colleagues performed a meta-analysis of the risk of lumbar fusion on THA 




relative novelty of the ideation that the spine has significant bearing on THA outcomes. They also identified a 
two-fold increased rate of dislocation and three-fold increased rate of revision in those patients who had a 
lumbar fusion prior to THA.5 However, this study was limited to the English literature, and did not assess 
other outcomes such as aseptic loosening or periprosthetic fracture, that we have anecdotally seen to be higher 
in this patient population. Furthermore they did not explore the association between rates and the number of 
spinal levels fused.  
 
Thus, we aimed to perform a comprehensive and generalisable assessment of adverse outcomes following 
primary THA in patients with or without prior spinal fusion surgery, using an updated systematic meta-
analysis of published studies.  
 
Materials and Methods 
Data sources and search strategy 
This review was conducted in accordance with PRISMA and MOOSE guidelines14,15 (Supplementary 
Materials 1-2) and based on a pre-defined protocol in the prospective register of systematic reviews, 
PROSPERO (CRD42018100565). The following databases were searched from inception to 28 October 2019: 
MEDLINE, Embase, and The Cochrane library. The search strategy was constructed by combining MeSH 
search terms and key words related to the exposure (e.g., “spinal fusion”, “spinal deformity”, “spinal 
stenosis”) and population (e.g., “primary total hip replacement”) and it was restricted to human studies with 
no limits on language. Details of the MEDLINE search strategy are reported in Supplementary Material 3. 
Initial screening of all titles and abstracts of studies retrieved from the databases was performed by one 
reviewer (MCW) to assess their potential for inclusion. This was then followed by the acquisition of full texts 
of potentially eligible studies and detailed evaluation which was done by 2 independent reviewers (MCW and 
SKK). Reference lists of relevant review articles and some of the included studies were manually assessed to 








Studies were eligible if they were comparative observational cohort designs, case-control designs, or 
randomised controlled trials (RCTs) that: (i) recruited participants undergoing primary THA; (ii) compared 
pre-existing spinal fusion surgery vs none; and (ii) reported any of the following outcomes after a period of 
follow-up following primary THA – dislocations, revisions, reasons for revision such as mechanical 
loosening, periprosthetic fracture, prosthetic joint infection (PJI), and any complications. No restrictions were 
imposed on the follow-up duration. We excluded the following studies: (i) those with no comparison or 
control groups; (ii) revision THAs; (iii) those that involved only particular indications for THA such as hip 
fracture; and (iv) those that included only hemiarthroplasty or hip resurfacing. 
 
Data extraction and quality assessment 
One reviewer (MCW) extracted study information into a standardised data collection spreadsheet. A second 
reviewer (SKK) then independently checked the extracted data with that in the original papers. Data was 
extracted on the following: first author’s name, study publication date, country and geographical location of 
study, study design, baseline year, mean age, duration of follow-up, sample size, outcomes, number of 
outcomes in each group, and risk estimates (relative risks (RRs), hazard ratios (HRs), or odds ratios (ORs)). 
We defined “short” spinal fusion as two or less motion segments fused and “long” spinal fusion as three of 
more segments fused. When the same study was described in multiple publications, the paper with the most 
comprehensive information was used. Methodological quality of each eligible study was assessed using the 
nine-star Newcastle-Ottawa Scale (NOS).16 NOS measures the quality of non-randomised studies from a score 
of zero to nine, based on three pre-defined domains including: (i) selection of participants; (ii) comparability 
of study groups; and (iii) ascertainment of outcomes of interest.  
 
Statistical analyses 
Relative risks (RRs) with 95% confidence intervals (CIs) were used as summary measures of associations 
across studies. Since the outcomes evaluated (e.g., dislocation, revision, PJI) can be considered a rare 
complication (prevalence < 10%), reported HRs and ORs were assumed to approximate the same measure of 




extracted for pooling when reported, otherwise crude RRs were calculated from the extracted raw counts. 
Random-effects models were used to combine RRs to minimise the effect of heterogeneity.18 Heterogeneity 
was assessed using the Cochrane χ2 statistic and the I2 statistic.19 The statistical analyses employed STATA 




Study identification and selection 
The literature search strategy and manual screening of references lists identified 329 potentially eligible 
articles. After screening of titles and abstracts, 75 articles remained for detailed full text evaluation. Following 
evaluation, 65 articles were excluded because (i) the exposure was not relevant (n=18); (ii) were based on 
reviews and letters (n=14); (iii) no appropriate control group (n=10); (iv) population not relevant (n=8); (v) 
were duplicates of studies already included in review (n=7); (vi) outcomes were not relevant (n=6); (vii) full 
text could not be retrieved (n=1); (viii) based on an abstract (n=1). The remaining 10 articles corresponding to 
9 unique studies were eligible to be included in the review20-29 (Figure 1). 
 
Study characteristics and quality 
The majority of studies were based on retrospective cohort designs with one based on a prospective cohort 
and another on a retrospective case-control design. No RCTs were identified. Publication dates of included 
articles ranged from 2016 to 2019. Relevant baseline characteristics and quality assessment scores of the 
individual articles/studies are summarized in Table 1. The 9 unique studies involved 1,992,366 primary 
THAs. There were 32,945 cases of spinal fusion and 1,752,362 non-cases. Overall, 7 studies were conducted 
in North America (USA), 1 in Europe (France) and 1 in Asia (Singapore). The average baseline age of 
participants in the included studies ranged from 64.5 to 71.0 years and the weighted mean age was 64.5 years. 
The average overall duration of follow-up for outcomes ranged from 90 days to 2.7 years, with a weighted 
mean follow-up duration of 0.9 years. Methodological quality of observational studies ranged from 4-8 using 







Spinal fusion and risk of outcomes 
A total of 7 studies comprising of 1,992,251 primary THAs contributed to the pooled analysis for dislocation.  
There were 32,817 cases of spinal fusion and 1,752,149 non-cases. The pooled RR (95% CI) of dislocation 
comparing patients with prior spinal fusion versus without was 2.23 (1.81-2.74) (Figure 2). There was 
evidence of significant heterogeneity between contributing studies (I2 =77%; 95% CI: 53-89%; p<0.001). One 
study could not be included in the pooled analysis because none of the patients in either group experienced a 
dislocation;24 this study did not provide details of the follow-up period, hence it is uncertain if the zero event 
rate could be attributed to lack of follow-up. Five studies comprising of 649,820 primary THAs contributed to 
the pooled analysis for revision and these included 10,569 cases of spinal fusion and 639,251 non-cases. The 
corresponding pooled RR (95% CI) for revision was 2.14 (1.63-2.83) (Figure 2) with evidence of moderate 
heterogeneity across the studies (I2 =53%; 95% CI: 0-83%; p=0.073). Comparing patients with prior spinal 
fusion to those without, the pooled RRs (95% CIs) for PJI (4 studies; 599,555 THAs; 9,909 spinal fusion and 
589,646 non-cases), periprosthetic fracture (3 studies; 599,391 THAs; 9,827 spinal fusion and 589,564 non-
cases), aseptic loosening (3 studies; 599,391 THAs; 9,827 spinal fusion and 589,564 non-cases), and any 
complications (3 studies; 649,020 THAs; 10,441 spinal fusion and 638,579 non-cases) were 1.71 (1.53-1.92), 
1.52 (1.28-1.81), 1.76 (1.54-2.01), and 2.82 (1.37-5.80) respectively (Figure 3). Note that variable number of 
studies in the pooled analysis relates to whether the individual article reported on the outcome of interest. 
Results from single reports showed no significant associations of prior spinal fusion with a discharge 
destination other than home, readmission or hardware complication (Figure 2). 
 
In studies that compared short spinal fusion (1 to 2-level lumbar fusion) or long spinal fusion (3 to 7-level 
lumbar fusion) with no spinal fusion, there was an increased risk of all outcomes evaluated (dislocation, 
revision, aseptic loosening, periprosthetic fracture, PJI, and any complications) (Supplementary Materials 4-
5). The risk of dislocation comparing short versus long spinal fusion was based on findings from two single 




spinal fusion RR (95% CIs) of 1.60 (1.24-2.07).3 The other study reported no significant difference in 
dislocation-free survival by level of fusion when comparing short versus long spinal fusions.27 
 
Discussion 
This systematic meta-analysis of observational studies shows that patients with a prior spinal fusion have a 
substantially and significantly increased risk of dislocation, revision, aseptic loosening, periprosthetic fracture, 
PJI, and other adverse events following primary THA compared to those without prior spinal fusion. 
Furthermore, both short and long spinal fusion, when compared with no fusion, are associated with increased 
risk of dislocation, revision and reasons for revision. 
 
The more than two-fold increased risk of dislocation identified in this study is consistent with that reported by 
An and colleagues.5 One can postulate that the alignment and rigidity imparted by lumbar fusion influences 
the outcome of THA by increasing the risk of dislocation, due to the lack of spinal compensation during 
motion, which would be consistent with the findings of Riviere and colleagues.13 Similarly, the 1.8 fold 
increased rate of implant aseptic loosening can be attributed to the stiff spine functionally adding a degree of 
constraint to the hip or a suboptimal functional acetabular orientation resulting in impingement and 
potentiating instability. edge loading and premature wear.10 Furthermore, poor functional implant positioning, 
a lack of spinal motion to compensate for impact during a fall, an increased risk of falling and implant aseptic 
loosening may account for the 1.5 fold increased risk of periprosthetic fracture.30 However, other factors such 
as the indication for the fusion and neurological dysfunction may confound these relationships by affecting 
the hip’s peri-articular neuromuscular function and increasing the risk of falls in these patients.  
 
With dislocation, aseptic loosening and fracture being increased in these patients it is not surprising that 
revision rates are 2.1 fold higher in patients with a prior lumbar fusion. However, it is harder to understand 
why PJI is increased unless the combination of a lumbar fusion and THA is an indication of a more comorbid, 





Of interest, the relative complication rates remain significant even in patients with a short segment fusion. 
This is likely explained by most short segment lumbar fusions involving the lower lumbar spine between L4 
and S1, which are known to provide the majority of lumbar lordosis and greatest effect on spinopelvic 
kinematics.31 Although not directly compared, the forest plots would suggest that longer segment fusions 
carry higher dislocation, implant aseptic loosening and revision rates than short segment fusions, which would 
support a biomechanical cause for these complications (Supplementary Materials 4-5).  
 
The results of this study permit a greater understanding of the implications of a prior fusion on the outcomes 
of a THA. The clinical relevance of which is to provides useful information to enable adequate counselling of 
the risks of THA and accounting for the patients spino-pelvic alignment when performing THA for these 
high-risk patients. However, it is unknown whether there is a need for surgical techniques to change. 
Contemporary techniques are available that attempt to determine the effects of an individual’s spinopelvic 
motion on a THA during pre-operative planning with dynamic radiographs and 3D modelling. These adjuncts, 
and a move toward functional positioning of THA implants may reduce the complication profile in this subset 
of patients, but further evaluation of this claim is necessary. It may be appropriate in patients with a higher 
risk of dislocation due to previous spinal fusion or stiffness to use dual mobility implants due to their large 
effect size in reducing the risk of dislocation in observational studies.32 
 
With ever increasing subspecialisation of hip arthroplasty surgeons and spinal surgeons, this research 
emphasises the importance of each discipline understanding the implications of pathology and interventions 
affecting other areas. A closer collaboration between these disciplines may improve patient outcomes as more 
knowledge is gained about the complex biomechanical interplay between the spine and hip. 
 
The current study has some advantages compared to the previous review. Firstly, included several recent 
published reports, hence there was enhanced power to evaluate the associations. Secondly, we reported on a 
comprehensive list of outcomes previously not evaluated by An and colleagues in their review.5 Lastly, we 
excluded two papers from the An et al. review, the first of which was the article by Perfetti and colleagues as 




publication of Diebo and colleagues.5,28,33 The second was the article by Eneqvist and colleagues which was 
excluded because it only reported patient reported outcomes.34  
 
There are several important limitations which deserve consideration. First, there was significant heterogeneity 
between the contributing studies which could be attributed to study design characteristics; however, this could 
not be explored because of the limited number of studies available for pooling in each outcome. Second, 
majority of the risk estimates were estimated from raw counts, hence inability to account for confounding was 
an issue. Third, this study could not assess the time between fusion and THA, the spinopelvic parameters, the 
underlying condition necessitating lumbar fusion or THA, nor could it assess the method and implant choice 
of either fusion of THA. Fourth, the length of follow-up (range 90 days to 2.7 years) of included studies was 
short and may impact the true risk differences at intermediate and long-term follow-up. We were unable to 
conduct any sensitivity analyses given the limited number of studies and the fact that not all evaluated 
outcomes were reported by each of the included studies. Fifth, although we assessed the associations between 
outcomes and short or long segment fusion, we could not stratify the risk according to the number of levels 
fused because these data were not available. Sixth, the incidence and influence of lumbar spinal pathology, 
including stiffness and deformity, in the non-fused on the outcome of this study remains unclear. Seventh, 
some of the findings were based on single reports. Finally, because of lack of or inconsistent reporting, we 
were unable to assess patient reported outcomes or satisfaction scores.  
 
Despite these limitations, this study has identified that patients with prior spinal fusion are at substantial risk 
of adverse events following primary THA, which suggests that measures to reduce the risk of these 
complications should be used in this high-risk population when undergoing primary THA. Additionally, these 
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Table 1. Baseline characteristics of included articles (studies) (2016-2019) 
Author, year of 
publication 
Country Year of study Study design Mean/median 
baseline age (years) 
Males (%) Follow-up period No. of THRs Quality score 
Sing, 2016 USA 2005-2012 Retrospective cohort <65-85+ 38.0 2.0 years 598,995 8 
Barry, 2017 USA 2012-2014 Retrospective cohort 68.4 42.9 90 days 105 7 
Buckland, 2017 USA 2005-2012 Retrospective cohort <65-85+* 38.5 1.0 year 853,677 8 
Lazennec, 2017 France 2013-2015 Retrospective case-
control 
60.1-64.9 39.1 NR 243 4 
Loh, 2017 Singapore 2006-2015 Prospective cohort 67.7 19.5 2.0 years 164 6 
Diebo, 2018 USA 2009-2013 Retrospective cohort 63-65 44.0 NR 49,920 7 
Gausden, 2018 USA 2012-2014 Retrospective cohort 64.5 45.1 6 months 207,285 6 
King, 2018 USA 2005-2014 Retrospective cohort >65 38.2 NR 880,405 5 
York, 2018 USA 2010-2014 Retrospective cohort 61.3-63.5 37.1 2.7 years 509 4 
Salib, 2019 USA 1998-2015 Retrospective cohort 71.0 44.0 6.0 years 291 6 






Figure 1. PRISMA flow diagram 
329 Potentially relevant citations identified
From MEDLINE, Embase, Web of Science, 
Cochrane Library, and reference list of 
relevant studies
254 excluded on the basis of title 
and/ or abstract
65 Articles excluded due to:
18 Exposure not relevant
14 Reviews and letters
10 No appropriate control
8 Population not relevant
7 Duplicates
6 Outcome not relevant
1 Full text not retrievable
1 Abstract
10 Articles included, based on 9 
unique studies




































Figure 2. Risk of dislocation and revision comparing prior spinal fusion with no spinal fusion 
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Figure 3. Risk of other complications comparing prior spinal fusion with no spinal fusion in 
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Supplementary Material 1 PRISMA checklist 
Supplementary Material 2 MOOSE checklist 
Supplementary Material 3 Literature search strategy 
Supplementary Material 4 Risk of outcomes comparing prior short spinal fusion with no spinal fusion in 
primary THR 


















2 Provide a structured summary including, as applicable, background, objectives, data sources, study 
eligibility criteria, participants, interventions, study appraisal and synthesis methods, results, 
limitations, conclusions and implications of key findings, systematic review registration number 
2 
Introduction 
Rationale 3 Describe the rationale for the review in the context of what is already known 4-5 
Objectives 4 Provide an explicit statement of questions being addressed with reference to participants, interventions, 





5 Indicate if a review protocol exists, if and where it can be accessed (such as web address), and, if 




6 Specify study characteristics (such as PICOS, length of follow-up) and report characteristics (such as 




7 Describe all information sources (such as databases with dates of coverage, contact with study authors 
to identify additional studies) in the search and date last searched 
6 
Search 8 Present full electronic search strategy for at least one database, including any limits used, such that it 
could be repeated 
Supplementary 
Material 3 
Study selection 9 State the process for selecting studies (that is, screening, eligibility, included in systematic review, and, 




10 Describe method of data extraction from reports (such as piloted forms, independently, in duplicate) 
and any processes for obtaining and confirming data from investigators 
6-7 
Data items 11 List and define all variables for which data were sought (such as PICOS, funding sources) and any 
assumptions and simplifications made 
6-7 
Risk of bias in 
individual 
studies 
12 Describe methods used for assessing risk of bias of individual studies (including specification of 





13 State the principal summary measures (such as risk ratio, difference in means). 7-8 
Synthesis of 
results 
14 Describe the methods of handling data and combining results of studies, if done, including measures of 
consistency (such as I2 statistic) for each meta-analysis 
7-8 
Risk of bias 
across studies 
15 Specify any assessment of risk of bias that may affect the cumulative evidence (such as publication 




16 Describe methods of additional analyses (such as sensitivity or subgroup analyses, meta-regression), if 
done, indicating which were pre-specified 
7-8 
Results 
Study selection 17 Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for 
exclusions at each stage, ideally with a flow diagram 
8 and Figure 1 
Study 
characteristics 
18 For each study, present characteristics for which data were extracted (such as study size, PICOS, 
follow-up period) and provide the citations 
8-9, Table 1 
Risk of bias 
within studies 




20 For all outcomes considered (benefits or harms), present for each study (a) simple summary data for 
each intervention group and (b) effect estimates and confidence intervals, ideally with a forest plot 
9-10, Figures 2-3 
Synthesis of 
results 
21 Present results of each meta-analysis done, including confidence intervals and measures of consistency 9-10, Figures 2-3; 
Supplementary 
Materials 4-5 
Risk of bias 
across studies 
22 Present results of any assessment of risk of bias across studies (see item 15)  
Additional 
analysis 
23 Give results of additional analyses, if done (such as sensitivity or subgroup analyses, meta-regression) 





24 Summarise the main findings including the strength of evidence for each main outcome; consider their 
relevance to key groups (such as health care providers, users, and policy makers) 
10 
Limitations 25 Discuss limitations at study and outcome level (such as risk of bias), and at review level (such as 
incomplete retrieval of identified research, reporting bias) 
13-14 




Funding 27 Describe sources of funding for the systematic review and other support (such as supply of data) and 





Supplementary Material 2. MOOSE checklist  
 
Outcomes following primary total hip replacement with pre-existing spinal fusion surgery: 
A systematic review and meta-analysis of observational evidence 
 
 
Criteria Brief description of how the criteria were handled in the review 
Reporting of background   
 Problem definition There is inconsistent evidence on whether prior spinal fusion surgery 
adversely impacts outcomes following total hip replacement (THR). 
 Hypothesis statement Prior spinal fusion surgery is associated with worse outcomes following THR 
 Description of study outcomes Dislocation, revision and reasons for revision 
 Type of exposure  Cemented, uncemented, hybrid, and reverse hybrid fixations 
 Type of study designs used Comparative observational studies and randomised controlled trials 
 Study population Primary THR 
Reporting of search strategy should include  
 Qualifications of searchers Setor K. Kunutsor, PhD; MC Wyatt 
 Search strategy, including time period 
included in the synthesis and keywords 
Time period: from inception to 28 Oct 2019  
The detailed search strategy can be found in Supplementary Material 3 
 Databases and registries searched MEDLINE, EMBASE, Web of Science, and Cochrane databases 
 Search software used, name and version, 
including special features 
OvidSP was used to search EMBASE and MEDLINE 
EndNote used to manage references  
 Use of hand searching We searched bibliographies of retrieved papers  
 List of citations located and those 
excluded, including justifications 
Details of the literature search process are outlined in the flow chart.  The 
citation list for excluded studies are available on request. 
 Method of addressing articles published 
in languages other than English 
Not applicable 
 Method of handling abstracts and 
unpublished studies 
Abstracts with no full text publications were not included. 
 Description of any contact with authors None 
Reporting of methods should include  
 Description of relevance or 
appropriateness of studies assembled for 
assessing the hypothesis to be tested 
Detailed inclusion and exclusion criteria are described in the Methods 
section. 
 Rationale for the selection and coding of 
data 
Data extracted from each of the studies were relevant to the population 
characteristics, study design, exposure, and outcome. 
 Assessment of confounding We assessed confounding by ranking individual studies on the basis of 
different adjustment levels  
 Assessment of study quality, including 
blinding of quality assessors; 
stratification or regression on possible 
predictors of study results 
Study quality was assessed based on the nine-star Newcastle–Ottawa Scale 
using pre-defined criteria namely: population representativeness, 
comparability (adjustment of confounders), ascertainment of outcome. 
Sensitivity analyses by several quality indicators such as study size, duration 
of follow-up, and adjustment factors. 
 Assessment of heterogeneity Heterogeneity of the studies was quantified with I2 statistic that provides the 
relative amount of variance of the summary effect due to the between-study 
heterogeneity  
 Description of statistical methods in 
sufficient detail to be replicated 
Description of methods of meta-analyses. We performed random effects 
meta-analysis with Stata 16. 
 Provision of appropriate tables and 
graphics 
Table 1; Figures 1-3; Supplementary Materials 4-5 
Reporting of results should include  
 Graph summarizing individual study 
estimates and overall estimate 
Figures 2-3; Supplementary Materials 4-5 
 Table giving descriptive information for 
each study included 
Table 1 
 Results of sensitivity testing 
 
Not applicable  
 Indication of statistical uncertainty of 
findings 
95% confidence intervals were presented with all summary estimates, I2 
values and results of sensitivity analyses 




 Quantitative assessment of bias Sensitivity analyses indicate heterogeneity in strengths of the association due 
to most common biases in observational studies.  The systematic review is 
limited in scope, as it involves published data. Individual participant data is 
needed. Limitations have been discussed. 
 
 Justification for exclusion All studies were excluded based on the pre-defined inclusion criteria in 
methods section. 
 Assessment of quality of included studies Brief discussion included in ‘Methods’ section 
Reporting of conclusions should include  
 Consideration of alternative explanations 
for observed results 
Discussion 
 Generalization of the conclusions Discussed in the context of the results. 
 Guidelines for future research Large-scale definitive studies needed 





Supplementary Material 3. Literature search strategy 
Relevant studies, published from inception to 28 October 2019 (date last searched), were identified through electronic searches using 
MEDLINE, EMBASE, and Cochrane databases. Electronic searches were supplemented by scanning reference lists of articles 
identified for all relevant studies (including review articles) and by hand searching of relevant journals.  
Ovid MEDLINE 1946-Present 
1     exp Spinal Fusion/ (22350) 
2     spinal deformity.mp. (3269) 
3     exp Spinal Curvatures/ (22206) 
4     exp Spinal Stenosis/ (5438) 
5     exp Arthroplasty, Replacement, Hip/ (23241) 
6     hip arthroplasty.mp. (18637) 
7     hip replacement.mp. (10187) 
8     1 or 2 or 3 or 4 (44893) 
9     5 or 6 or 7 (35143) 
10     8 and 9 (121) 
11     limit 10 to humans (117) 
 
 







































































Favours prior fusion Favours no prior fusion  
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Favours prior fusion Favours no prior fusion
 
CI, confidence interval (bars); PJI, prosthetic joint infection; RR, relative risk; THR, total hip replacement 
 
 
 
  
 
 
 
